Announcement of Resolutions of the First Meeting of the Sixth Board of Directors of Jimin Health Management Co., Ltd.
Securities code: 603222 Securities abbreviation: Jimin Health Announcement number: 2025-060
Jimin Health Management Co., Ltd.
Announcement of Resolutions of the First Meeting of the Sixth Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and bear individual and joint liability for the authenticity, accuracy and completeness of its contents.
1. Convening of board of directors meetings:
The first meeting of the sixth board of directors of Jimin Health Management Co., Ltd. (hereinafter referred to as the "Company") was held on the morning of December 2, 2025, on the morning of December 2, 2025 through on-site and communication voting. The meeting notice was sent by phone, email and written form on November 27, 2025. This meeting was presided over by the director Mr. Xu Zan. 9 directors should be present, but 9 directors were actually present. The meeting was convened and held in compliance with the relevant provisions of the Company Law and the Articles of Association, and the meeting was legal and valid.
2. Review status of board of directors meeting:
After careful deliberation by the directors present at the meeting, the following resolutions were reached:
(1) The "Proposal on the Election of Chairman of the Company's Sixth Board of Directors" was reviewed and passed with 9 votes in favor, 0 votes against, and 0 abstentions.
It was agreed to elect Mr. Xu Zan as the chairman of the sixth session of the Board of Directors of the company, with a term of office until the expiration date of the sixth session of the Board of Directors.
(2) The "Proposal on the Election of Members and Convener of the Special Committee of the Sixth Board of Directors" was reviewed and passed with 9 votes in favor, 0 votes against, and 0 abstentions.
It is agreed to elect the following persons to form the members and conveners of the special committees of the sixth session of the Board of Directors of the company. The term of each special committee member shall be until the expiration date of the sixth session of the Board of Directors.
Convener Xu Zan
Jimin Health Management Unit
Co., Ltd. Sixth Tian Yunfei
strategy committee
Special Committee Member of the 2016 Board of Directors Qiu Gaopeng
committee
Chen Kun
Wang Chengbin
Convener Wang Chengbin
Nomination Committee Tian Yunfei
member
Wang Xingbin
Convener Zheng Feng
Remuneration and Appraisal Committee Wang Xingbin
member
Tian Yunfei
Convener Wang Xingbin
Audit Committee Shangguan Fudan
member
Wang Chengbin
(3) The "Proposal on Appointing the President of the Company" was reviewed and passed with 9 votes in favor, 0 votes against, and 0 abstentions.
In accordance with the relevant provisions of the Company Law and the Articles of Association, after a qualification review by the Nomination Committee of the Board of Directors and a proposal to the Board of Directors, it was agreed to appoint Mr. Tian Yunfei as the president of the company and the legal representative of the company until the expiration of the sixth session of the Board of Directors.
(4) The "Proposal on Appointment of Secretary to the Company's Board of Directors" was reviewed and passed with 9 votes in favor, 0 votes against, and 0 abstentions.
In accordance with the relevant provisions of the Company Law and the Articles of Association, after a qualification review by the Nomination Committee of the Board of Directors and a proposal to the Board of Directors, it was agreed to appoint Mr. Chen Kun as Secretary of the Company’s sixth Board of Directors, with the same term as the Company’s Sixth Board of Directors.
Chen Kun has obtained the qualification to serve as secretary of the board of directors of the Shanghai Stock Exchange and has the necessary professional knowledge to perform the duties of secretary to the board of directors. His qualifications comply with relevant laws and regulations and have been reviewed and approved by the Shanghai Stock Exchange.
(5) The "Proposal on the Appointment of Other Senior Management Personnel of the Company" was reviewed and passed with 9 votes in favor, 0 votes against, and 0 abstentions.
In accordance with the provisions of the Company Law and the Articles of Association, after being nominated by the general manager of the company, subject to qualification review by the nomination committee of the board of directors and proposed to the board of directors, it was agreed to appoint Mr. Qiu Gaopeng as the company's executive vice president; Mr. Chen Kun as the company's vice president and secretary of the board of directors; Mr. Bie Yong as the company's vice president; and Mr. Yang Guowei as the company's financial officer. The terms of the above-mentioned personnel are the same as the terms of the sixth term of the Company’s Board of Directors. The above-mentioned personnel meet the qualification requirements for senior managers in relevant laws, administrative regulations and normative documents.
The appointment of the financial director has been reviewed and approved by the Audit Committee of the company's board of directors and agreed to be submitted to the board of directors for review.
(6) The "Proposal on the Appointment of the Company's Securities Affairs Representative and the Head of the Internal Audit Department" was reviewed and approved with 9 votes in favor, 0 votes against, and 0 abstentions.
In accordance with the provisions of the "Shanghai Stock Exchange Stock Listing Rules" and the company's "Working Rules for the Secretary of the Board of Directors", it is proposed to appoint Ms. Pan Min as the company's securities affairs representative to assist the secretary of the board of directors in performing his duties; in accordance with the provisions of the company's internal audit system, it is agreed to appoint Bao Xiaojing as the head of the company's internal audit department. The terms of the above-mentioned personnel are the same as the terms of the sixth term of the Company’s Board of Directors.
Please see the attachment for the resumes of the above personnel.
Announcement is hereby made.
Jimin Health Management Co., Ltd. Board of Directors
December 3, 2025 Attached: Resume
Xu Zan, male, Chinese nationality, born in November 1981, master's degree, certified public accountant, no permanent residence abroad, member of Jiusan Society. From July 2009 to October 2010, he served as the audit manager of Lixin Accounting Firm (Special General Partnership); from October 2010 to October 2011, he served as the financial director of Ningbo Bo Yang Technology Co., Ltd.; from October 2011 to September 2019, he served as the deputy general manager, director, board secretary, and financial director of Ningbo Jizhi Technology Co., Ltd.; from April 2017 to October 2019 From November 2019 to December 2021, he served as executive director and general manager of Shanghai Luzai Information Technology Co., Ltd.; from December 2021 to May 2024, he served as executive director of Hainan Defema Venture Capital Fund Co., Ltd.; from May 2024 to June 2025, he served as financial director and secretary of the board of directors of Shanghai Lingshu Technology Co., Ltd.; and independent director of the fifth board of directors of Jimin Health. From July 2025 to present, he has served as executive director and general manager of Shanghai Chiyaoshe Cultural Communication Co., Ltd.; from June 2020 to present, he has served as independent director of Chuangyao (Suzhou) Communication Technology Co., Ltd.
Tian Yunfei, male, Chinese nationality, born in March 1980, holds a master's degree and has permanent residence abroad. Since joining the company in April 2008, he has served as Jimin Pharmaceutical Production Department Manager, Assistant to the General Manager, Deputy General Manager of Shuangge Group, General Manager of Shuangge Group, and Executive Director and Manager of Shuangge New Energy; his social positions include representatives of the 11th and 12th Zhejiang Provincial People’s Congress. He is currently the director and president of the company and the general manager of Boao International Hospital.
Qiu Gaopeng, male, Chinese nationality, born in August 1972, master's degree, senior economist, no permanent residence abroad. From June 2010 to June 2011, he served as the director of the marketing department of Huafang Pharmaceutical Technology of Holley Group; from June 2011 to June 2013, he served as the director and general manager of Zhejiang Woxin Woneng Technology Co., Ltd.; he joined the company in June 2013 and currently serves as the company director, the company's executive vice president, the general manager of Jimintang, and concurrently serves as the executive director of Ezhou Second Hospital. Social positions held include member of the 14th CPPCC Huangyan District Committee, member of the Standing Committee of the 15th CPPCC Huangyan District Committee, executive director of the Zhejiang Pharmaceutical Association, and director of the 4th Taizhou Pharmaceutical Association.
Chen Kun, male, Chinese nationality, born in March 1982, master's degree, certified public accountant, no permanent residence abroad. From 2009 to 2011, he worked in the Investment Banking Department of Western Securities as a project manager; from 2011 to 2016, he worked in the Investment Banking Department of GF Securities as a sponsor representative; from 2016 to 2018, he worked in Xi'an Reddy Information Technology Co., Ltd. as a director, financial director and board secretary. He joined the company in April 2018 and has served as the company's director, vice president and financial director. He is currently a director, vice president and secretary of the board of directors of the company.
Wang Xingbin, male, Chinese nationality, born in July 1977, master's degree, senior accountant, certified public accountant, certified tax agent, asset appraiser, no permanent residence abroad. From December 2002 to present, he has served as the deputy director of Zhejiang Zhonghe United Accountants Firm (general partnership); from October 2012 to present, he has served as executive partner of Taizhou Zhenghe Tax Accountants Firm (general partnership); from May 2020 to present, he has served as director of Zhejiang Yuncheng Holding Group Co., Ltd. (unlisted company); from August 2020 to present, he has served as independent director of Zhejiang Shuangsen Metal Technology Co., Ltd. (unlisted company); from November 2020 to present In July 2025, he was appointed as an independent director of Zhejiang Haisheng Pharmaceutical Co., Ltd.; from August 2021 to present, he was appointed as executive director and manager of Yige Enterprise Management (Taizhou) Co., Ltd.; from December 2020 to present, he was appointed as an independent director of Hengbo Holdings Co., Ltd.
Wang Chengbin, male, Chinese nationality, born in February 1969, Ph.D., senior economist, no permanent residence abroad. From September 2003 to present, he has served as a teacher at Taizhou University and is currently a professor at the Business School of Taizhou University; from May 2015 to present, he has served as a director of Zhejiang Sanmen Rural Commercial Bank Co., Ltd.
Zheng Feng, female, Chinese nationality, born in July 1966, has a bachelor's degree and no permanent residence abroad. From August 1987 to January 2003, he served as clerk and deputy manager of the management department of the Zhejiang Taizhou Branch of China Foreign Trade and Transportation Corporation; from February 2003 to January 2011, he served as a law partner of Zhejiang Liqun Law Firm; from March 2011 to present, he served as a senior partner of Zhejiang Duolian Law Firm, and concurrently served as an independent director of Zhejiang Yeguangming Optoelectronics Technology Co., Ltd., Zhejiang Yongtai Technology Co., Ltd., and Jimin Health.
Shangguan Fudan, male, Chinese nationality, born in September 1978, junior college, no permanent residence abroad. He once served as the director of the company's first workshop, director of the infusion workshop, manager of the production management department, and chief supervisor of the fifth supervisory board of Jimin Health. Currently the production director of the company.
Bie Yong, male, Chinese nationality, born in February 1975, master's degree, no permanent residence abroad. He has successively served as the manager of the Academic Exchange Center of Shandong University and the general manager of Shanghai Shuangge Industrial Co., Ltd. He is currently the general manager of Shanghai Jumin Biotechnology Co., Ltd. and the vice president of Jimin Health.
Yang Guowei, male, Chinese nationality, born in December 1982, has a bachelor's degree and no permanent residence abroad. Senior accountant, high-end international accounting talent in Zhejiang Province. He joined the company's finance department in September 2005 and served successively as the company's cost accountant, deputy manager of the finance department, manager of the finance department, and head of the company's accounting department (accounting supervisor). Currently the company's financial director.
Pan Min, female, Chinese nationality, born in July 1976, bachelor's degree, intermediate human resources manager, securities practitioner qualification certificate, no permanent residence abroad. From May 2008 to April 2010, he served as the assistant director of the office of Shuangge Group Co., Ltd. In May 2010, he served as the director office of Jimin Pharmaceutical. From April 2015 to the present, he served as the company’s securities affairs representative.
Bao Xiaojing, female, Chinese nationality, born in July 1997, bachelor's degree, certified public accountant, intermediate accounting qualification certificate, securities practitioner qualification certificate, no permanent residence abroad. From January 2020 to January 2022, he served as the accountant receivable of Yibai Media Exhibition (Shanghai) Co., Ltd.; from July 2022 to May 2024, he served as the senior auditor of Tianjian Accounting Firm (Special General Partnership); from December 2024 to the present, he served as the manager of the company's internal audit department.